We are live on
!
Find out more
ZAM
Zevin Asset Management Portfolio holdings
AUM
$723M
1-Year Est. Return
15.62%
This Fund
S&P 500
This Quarter
Est. Return
+0.2%
1 Year Est. Return
+15.62%
3 Year Est. Return
+57.49%
5 Year Est. Return
+80.59%
10 Year Est. Return
+296.42%
AUM
$383M
AUM Growth
+$73.2M
(+24%)
Cap. Flow
+$74M
Cap. Flow
% of AUM
19.31%
Top 10 Holdings %
Top 10 Hldgs %
44.39%
Holding
121
New
10
Increased
57
Reduced
30
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever
UL
|
+$20.9M |
| 2 |
Colgate-Palmolive
CL
|
+$12M |
| 3 |
iShares MSCI KLD 400 Social ETF
DSI
|
+$11.5M |
| 4 |
TJX Companies
TJX
|
+$8.46M |
| 5 |
Visa
V
|
+$6.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$9.65M |
| 2 |
Abbott
ABT
|
+$8.3M |
| 3 |
Illumina
ILMN
|
+$3.06M |
| 4 |
TGNA
TEGNA Inc
TGNA
|
+$2.73M |
| 5 |
CVS Health
CVS
|
+$1.79M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 15.34% |
| 2 | Consumer Discretionary | 15.27% |
| 3 | Technology | 12.35% |
| 4 | Industrials | 10.45% |
| 5 | Communication Services | 10.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TIF
76
DELISTED
Tiffany & Co.
TIF
| $348K | 0.09% |
4,500
| – | – |
|
77
Pfizer
PFE
$140B
| $339K | 0.09% |
+10,996
| New | +$336K |
|
78
Berkshire Hathaway Class B
BRK.B
$1.07T
| $332K | 0.09% |
+2,040
| New | +$314K |
|
79
Merck
MRK
$324B
| $302K | 0.08% |
+5,368
| New | +$314K |
|
|
K
80
DELISTED
Kellanova
K
| $291K | 0.08% |
+4,207
| New | +$293K |
|
81
Cisco
CSCO
$450B
| $283K | 0.07% |
9,380
+53
| +0.6% | +$1.62K |
|
82
American Express
AXP
$223B
| $269K | 0.07% |
3,630
+16
| +0.4% | +$1.11K |
|
83
Texas Instruments
TXN
$255B
| $269K | 0.07% |
3,692
+36
| +1% | +$2.57K |
|
|
VAR
84
DELISTED
Varian Medical Systems, Inc.
VAR
| $269K | 0.07% |
3,421
| – | – |
|
|
85
Abbott
ABT
$180B
| $259K | 0.07% |
6,753
-209,231
| -97% | -$8.3M |
|
86
Nike
NKE
$61.9B
| $244K | 0.06% |
4,800
| – | – |
|
87
CenterPoint Energy
CNP
$29.1B
| $223K | 0.06% |
9,040
-625
| -6% | -$14.6K |
|
88
Union Pacific
UNP
$183B
| $220K | 0.06% |
2,126
| – | – |
|
|
SPWR
89
DELISTED
SunPower Corporation Common Stock
SPWR
| $154K | 0.04% |
35,526
-7,749
| -18% | -$37.9K |
|
90
Gilead Sciences
GILD
$161B
| – | – |
-4,400
| Closed | -$348K |
|
|
91
Illumina
ILMN
$29.4B
| – | – |
-17,286
| Closed | -$3.06M |
|
92
Lumen
LUMN
$6.53B
| – | – |
-7,335
| Closed | -$201K |
|
93
Sprouts Farmers Market
SFM
$7.04B
| – | – |
-16,000
| Closed | -$330K |
|
|
TGNA
94
DELISTED
TEGNA Inc
TGNA
| – | – |
-195,172
| Closed | -$2.73M |
|
Similar funds
PPW
VCM
FFM
AGAM
ZDA
FIS
TFHU
FAN
Zevin Asset Management's Q4 2016 Portfolio in Review
As of Q4 2016, Zevin Asset Management held 121 positions worth $383M, up 24% from $310M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Zevin Asset Management deployed $74M of net new capital in Q4 2016, opening 10 new positions and adding to 57 existing holdings. Its largest new stake was iShares MSCI KLD 400 Social ETF: 283,870 shares worth $11.7M.
By sector, the portfolio is most concentrated in Consumer Staples at 15% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Target, an estimated $9.65M trimmed.
- Zevin Asset Management's largest Q4 2016 buy was iShares MSCI KLD 400 Social ETF: 283,870 shares worth $11.7M.
- Zevin Asset Management added most to Unilever in Q4 2016, an estimated $20.9M increase.
- Zevin Asset Management's biggest Q4 2016 reduction was Target, cutting an estimated $9.65M.
- Zevin Asset Management fully exited Illumina in Q4 2016, selling an estimated $3.06M.
- Zevin Asset Management's ten largest holdings make up 44% of its $383M portfolio in Q4 2016.
- Zevin Asset Management opened 10 new positions and closed 5 in Q4 2016.
- Zevin Asset Management's portfolio value rose 24% quarter-over-quarter to $383M.
Based on Zevin Asset Management's 13F filing for Q4 2016, filed 17 Feb 2017.